Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00272740
Status:
COMPLETED
Last Update Posted:
2007-02-09
First Post:
2006-01-04
Brief Title:
SAKK - a Trial to Evaluate Antitumor Efficacy of Faslodex After Aromatase Inhibitor Failure in Advanced Breast Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca